Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients.

about

IL-27 - a double agent in the IL-6 family.

P2860

Q50045633-0ED5F31D-3752-4476-A934-B11E80FB47E6

P2860

Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients.

Item

http://www.wikidata.org/entity/Q51087844

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@en

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@nl

type

Item

label

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@en

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@nl

prefLabel

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@en

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@nl

P1476

Pre-treatment interleukin-6 le ...... rheumatoid arthritis patients.

@en

P2093

Hiroaki Sugiura

http://www.w3.org/2001/XMLSchema#string

Masahiro Jinzaki

http://www.w3.org/2001/XMLSchema#string

Masataka Kuwana

http://www.w3.org/2001/XMLSchema#string

Naoshi Nishina

http://www.w3.org/2001/XMLSchema#string

Shunsuke Matsumoto

http://www.w3.org/2001/XMLSchema#string

Yasushi Kondo

http://www.w3.org/2001/XMLSchema#string

Yuko Kaneko

http://www.w3.org/2001/XMLSchema#string

P2860

IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism?

The pathogenesis of rheumatoid arthritis

Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study.

A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.

Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.

Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.

P304

1089-1094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX046

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsutomu Takeuchi

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28340008

http://www.w3.org/2001/XMLSchema#string

Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients.

about

P2860

P2860

Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698